Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
23
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Thorp Clay | Director, 10% Owner | 68 | $5.55M | $7.88M | 2025-02-24 |
| Chong Ngai Hang Victor | Chief Medical Officer | 5 | $109.4K | $0 | 2025-01-08 |
| Deignan Charles A. | Chief Financial Officer | 38 | $35.1K | $115.0K | 2025-01-08 |
| LASEZKAY GEORGE M | Interim CEO | 28 | $13.9K | $248.5K | 2025-01-08 |
| Gibney Anthony S | Director | 4 | $129.7K | $0 | 2024-06-20 |
| Humphries William D. | Director | 14 | $9.9K | $0 | 2024-06-20 |
| Croarkin Richard | Director | 9 | $0 | $0 | 2024-06-20 |
| Hutson Nancy J | Director | 15 | $90.3K | $0 | 2024-06-20 |
| EDWARDS JEFFREY L | Director | 7 | $0 | $0 | 2024-06-20 |
| SHAFFER CHRISTY L | Director | 12 | $31.7K | $0 | 2024-06-20 |
| YERXA BENJAMIN R | Director | 5 | $10.2K | $0 | 2024-06-20 |
| WHITMORE BRADFORD T | 10% Owner | 17 | $3.25M | $2.92M | 2024-02-07 |
| Ciulla Thomas | Chief Medical Officer | 14 | $0 | $59.3K | 2023-01-20 |
| Raymond Brion S. | Chief Commercial Officer | 3 | $0 | $0 | 2019-05-31 |
| White Daniel H. | President and CEO | 37 | $99.8K | $452.4K | 2019-02-05 |
| Cagle Gerald D. | Director | 18 | $258.6K | $14 | 2018-06-25 |
| Zaytsev Evgeny | Director | 3 | $0 | $0 | 2018-06-20 |
| Noronha Glenn | Executive Vice President, R&D | 3 | $0 | $0 | 2017-12-08 |
| Yoon Derek | Director | 2 | $0 | $0 | 2017-06-30 |
| Hatteras Venture Advisors III, LLC | 10% Owner | 3 | $0 | $218.2K | 2017-01-19 |
| Reed Douglas MD | 10% Owner | 3 | $0 | $255.8K | 2017-01-19 |
| RusnanoMedInvest LLC | 10% Owner | 3 | $300.0K | $0 | 2016-06-07 |
| INGRAM ROBERT ALEXANDER | 10% Owner | 19 | $3.65M | $966 | 2016-06-07 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Thorp Clay | Director | P Buy | 2025-02-24 | 2025-02-24 | 15,000 | $0.92 | $13.8K | 176,141 | SEC↗ |
| LASEZKAY GEORGE M | CEO | A Award deriv | 2025-01-08 | 2025-01-10 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Chong Ngai Hang Victor | Chief Medical Officer | A Award deriv | 2025-01-08 | 2025-01-10 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award deriv | 2025-01-08 | 2025-01-10 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Chong Ngai Hang Victor | Chief Medical Officer | P Buy | 2024-11-01 | 2024-11-04 | 36,500 | $1.00 | $36.5K | 100,000 | SEC↗ |
| Chong Ngai Hang Victor | Chief Medical Officer | P Buy | 2024-06-24 | 2024-06-24 | 23,500 | $1.06 | $24.9K | 63,500 | SEC↗ |
| SHAFFER CHRISTY L | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Thorp Clay | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Humphries William D. | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| EDWARDS JEFFREY L | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Croarkin Richard | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Hutson Nancy J | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| YERXA BENJAMIN R | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Gibney Anthony S | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| YERXA BENJAMIN R | Director | P Buy | 2024-05-15 | 2024-05-15 | 7,813 | $1.31 | $10.2K | 17,957 | SEC↗ |
| Gibney Anthony S | Director | P Buy | 2024-04-18 | 2024-04-19 | 93,290 | $1.30 | $121.3K | 100,000 | SEC↗ |
| Gibney Anthony S | Director | P Buy | 2024-04-17 | 2024-04-19 | 6,710 | $1.25 | $8.4K | 6,710 | SEC↗ |
| Gibney Anthony S | Director | A Award deriv | 2024-04-15 | 2024-04-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Chong Ngai Hang Victor | CHIEF MEDICAL OFFICER | P Buy | 2024-03-20 | 2024-03-20 | 30,000 | $1.60 | $48.0K | 30,000 | SEC↗ |
| Chong Ngai Hang Victor | CHIEF MEDICAL OFFICER | A Award deriv | 2024-03-18 | 2024-03-18 | 450,000 | — | $0 | 450,000 | SEC↗ |
| WHITMORE BRADFORD T | 10% Owner | P Buy deriv | 2024-02-07 | 2024-02-09 | 444,444 | — | $0 | 444,444 | SEC↗ |
| WHITMORE BRADFORD T | 10% Owner | P Buy | 2024-02-07 | 2024-02-09 | 444,444 | $1.35 | $600.0K | 4,495,034 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | S Sale | 2024-01-19 | 2024-01-19 | 12,900 | $1.28 | $16.5K | 384,662 | SEC↗ |
| LASEZKAY GEORGE M | CEO | S Sale | 2024-01-19 | 2024-01-19 | 18,000 | $1.27 | $22.9K | 466,577 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award deriv | 2024-01-18 | 2024-01-19 | 200,000 | — | $0 | 200,000 | SEC↗ |
| LASEZKAY GEORGE M | CEO | A Award deriv | 2024-01-18 | 2024-01-19 | 439,500 | — | $0 | 439,500 | SEC↗ |
| WHITMORE BRADFORD T | 10% Owner | P Buy | 2023-11-01 | 2023-11-01 | 64,366 | $0.74 | $47.6K | 4,050,590 | SEC↗ |
| WHITMORE BRADFORD T | 10% Owner | P Buy | 2023-10-31 | 2023-11-01 | 70,812 | $0.73 | $51.7K | 3,986,224 | SEC↗ |
| WHITMORE BRADFORD T | 10% Owner | P Buy | 2023-10-30 | 2023-11-01 | 600 | $0.69 | $414 | 3,915,412 | SEC↗ |
| Hutson Nancy J | Director | P Buy | 2023-10-03 | 2023-10-04 | 10,000 | $0.86 | $8.6K | 93,000 | SEC↗ |
| Thorp Clay | Director | P Buy | 2023-09-25 | 2023-09-25 | 10,000 | $0.86 | $8.6K | 40,522 | SEC↗ |
| Humphries William D. | Director | M Exercise deriv | 2023-09-22 | 2023-09-22 | 22,727 | — | $0 | 0 | SEC↗ |
| Humphries William D. | Director | M Exercise | 2023-09-22 | 2023-09-22 | 22,727 | $0.40 | $9.1K | 51,040 | SEC↗ |
| LASEZKAY GEORGE M | CEO | A Award deriv | 2023-09-18 | 2023-09-20 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award deriv | 2023-09-18 | 2023-09-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | M Exercise deriv | 2023-09-13 | 2023-09-13 | 34,090 | — | $0 | 0 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | M Exercise | 2023-09-13 | 2023-09-13 | 34,090 | $0.40 | $13.6K | 397,562 | SEC↗ |
| YERXA BENJAMIN R | Director | A Award deriv | 2023-06-22 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SHAFFER CHRISTY L | Director | A Award deriv | 2023-06-22 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Hutson Nancy J | Director | A Award deriv | 2023-06-22 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Humphries William D. | Director | A Award deriv | 2023-06-22 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| EDWARDS JEFFREY L | Director | A Award deriv | 2023-06-22 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Croarkin Richard | Director | A Award deriv | 2023-06-22 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Thorp Clay | Director | A Award deriv | 2023-06-22 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Ciulla Thomas | Chief Medical Officer | S Sale | 2023-01-20 | 2023-01-20 | 13,700 | $1.47 | $20.1K | 291,890 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | S Sale | 2023-01-19 | 2023-01-20 | 14,030 | $1.50 | $21.0K | 363,472 | SEC↗ |
| LASEZKAY GEORGE M | CEO | S Sale | 2023-01-19 | 2023-01-20 | 20,030 | $1.46 | $29.2K | 484,577 | SEC↗ |
| Ciulla Thomas | Chief Medical Officer | S Sale | 2023-01-10 | 2023-01-11 | 2,170 | $1.62 | $3.5K | 305,590 | SEC↗ |
| Ciulla Thomas | Chief Medical Officer | A Award deriv | 2023-01-04 | 2023-01-06 | 187,500 | — | $0 | 187,500 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award deriv | 2023-01-04 | 2023-01-06 | 187,500 | — | $0 | 187,500 | SEC↗ |
| LASEZKAY GEORGE M | CEO | A Award deriv | 2023-01-04 | 2023-01-06 | 487,500 | — | $0 | 487,500 | SEC↗ |
| Ciulla Thomas | Chief Medical Officer | A Award | 2022-12-31 | 2023-01-06 | 5,000 | $0.95 | $4.8K | 307,760 | SEC↗ |
| Thorp Clay | Director | P Buy | 2022-12-21 | 2022-12-21 | 14,000 | $1.02 | $14.3K | 30,522 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | M Exercise deriv | 2022-12-20 | 2022-12-20 | 23,636 | — | $0 | 0 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | M Exercise | 2022-12-20 | 2022-12-20 | 23,636 | $0.40 | $9.5K | 377,502 | SEC↗ |
| Thorp Clay | Director | J Other | 2022-12-15 | 2022-12-19 | 8,522 | — | $0 | 16,522 | SEC↗ |
| Thorp Clay | Director | J Other | 2022-12-15 | 2022-12-19 | 1,406,507 | — | $0 | 3,545,040 | SEC↗ |
| Hutson Nancy J | Director | P Buy | 2022-11-17 | 2022-11-21 | 30,000 | $1.33 | $39.9K | 83,000 | SEC↗ |
| Ciulla Thomas | Chief Medical Officer | A Award | 2022-06-30 | 2023-01-06 | 5,000 | $1.25 | $6.3K | 302,760 | SEC↗ |
| Thorp Clay | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Humphries William D. | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| EDWARDS JEFFREY L | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Croarkin Richard | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Hutson Nancy J | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| YERXA BENJAMIN R | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SHAFFER CHRISTY L | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| YERXA BENJAMIN R | Director | A Award deriv | 2022-03-02 | 2022-03-04 | 30,000 | — | $0 | 30,000 | SEC↗ |
| LASEZKAY GEORGE M | CEO | S Sale | 2022-01-19 | 2022-01-20 | 10,800 | $2.12 | $22.9K | 504,607 | SEC↗ |
| Ciulla Thomas | Chief Medical Officer | S Sale | 2022-01-19 | 2022-01-20 | 9,050 | $2.13 | $19.3K | 295,260 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | S Sale | 2022-01-19 | 2022-01-20 | 8,833 | $2.09 | $18.5K | 351,366 | SEC↗ |
| LASEZKAY GEORGE M | CEO | A Award deriv | 2022-01-18 | 2022-01-20 | 292,500 | — | $0 | 292,500 | SEC↗ |
| Ciulla Thomas | Chief Medical Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 131,250 | — | $0 | 131,250 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 131,250 | — | $0 | 131,250 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award deriv | 2022-01-18 | 2022-01-28 | 138,750 | — | $0 | 138,750 | SEC↗ |
| Ciulla Thomas | Chief Medical Officer | A Award deriv | 2022-01-18 | 2022-01-28 | 138,750 | — | $0 | 138,750 | SEC↗ |
| LASEZKAY GEORGE M | CEO | A Award | 2022-01-18 | 2022-01-20 | 97,500 | — | $0 | 515,407 | SEC↗ |
| Ciulla Thomas | Chief Medical Officer | A Award | 2022-01-18 | 2022-01-20 | 43,750 | — | $0 | 299,310 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award | 2022-01-18 | 2022-01-20 | 43,750 | — | $0 | 360,199 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award | 2022-01-18 | 2022-01-28 | 46,250 | — | $0 | 362,699 | SEC↗ |
| Ciulla Thomas | Chief Medical Officer | A Award | 2022-01-18 | 2022-01-28 | 46,250 | — | $0 | 301,810 | SEC↗ |
| LASEZKAY GEORGE M | CEO | S Sale | 2022-01-11 | 2022-01-13 | 5,100 | $2.46 | $12.5K | 417,907 | SEC↗ |
| Humphries William D. | Director | M Exercise deriv | 2022-01-10 | 2022-01-11 | 22,727 | — | $0 | 0 | SEC↗ |
| Humphries William D. | Director | M Exercise | 2022-01-10 | 2022-01-11 | 22,727 | $0.15 | $3.4K | 28,313 | SEC↗ |
| Hutson Nancy J | Director | M Exercise deriv | 2021-10-29 | 2021-11-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Hutson Nancy J | Director | M Exercise deriv | 2021-10-29 | 2021-11-02 | 25,000 | — | $0 | 0 | SEC↗ |
| Hutson Nancy J | Director | M Exercise | 2021-10-29 | 2021-11-02 | 25,000 | $2.00 | $50.0K | 38,000 | SEC↗ |
| Hutson Nancy J | Director | M Exercise | 2021-10-29 | 2021-11-02 | 15,000 | $2.09 | $31.3K | 53,000 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | S Sale | 2021-09-21 | 2021-09-23 | 2,800 | $6.41 | $17.9K | 316,449 | SEC↗ |
| LASEZKAY GEORGE M | CEO | S Sale | 2021-09-21 | 2021-09-23 | 3,525 | $6.46 | $22.8K | 423,007 | SEC↗ |
| Ciulla Thomas | Chief Medical Officer | S Sale | 2021-09-21 | 2021-09-23 | 2,560 | $6.40 | $16.4K | 255,560 | SEC↗ |
| WHITMORE BRADFORD T | 10% Owner | S Sale | 2021-09-01 | 2021-09-01 | 213,203 | $6.89 | $1.47M | 2,415,056 | SEC↗ |
| WHITMORE BRADFORD T | 10% Owner | S Sale | 2021-08-31 | 2021-09-01 | 107,682 | $6.96 | $749.5K | 2,628,259 | SEC↗ |
| WHITMORE BRADFORD T | 10% Owner | S Sale | 2021-08-30 | 2021-09-01 | 99,400 | $7.06 | $701.8K | 2,735,941 | SEC↗ |
| Hutson Nancy J | Director | P Buy | 2021-08-16 | 2021-08-17 | 3,000 | $5.68 | $17.0K | 13,000 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | S Sale | 2021-06-21 | 2021-06-23 | 2,938 | $4.37 | $12.8K | 319,249 | SEC↗ |
| LASEZKAY GEORGE M | CEO | S Sale | 2021-06-21 | 2021-06-23 | 3,707 | $4.38 | $16.2K | 426,532 | SEC↗ |
| SHAFFER CHRISTY L | Director | A Award deriv | 2021-06-10 | 2021-06-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Thorp Clay | Director | A Award deriv | 2021-06-10 | 2021-06-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Humphries William D. | Director | A Award deriv | 2021-06-10 | 2021-06-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EDWARDS JEFFREY L | Director | A Award deriv | 2021-06-10 | 2021-06-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Croarkin Richard | Director | A Award deriv | 2021-06-10 | 2021-06-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hutson Nancy J | Director | A Award deriv | 2021-06-10 | 2021-06-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LASEZKAY GEORGE M | CEO | S Sale | 2021-03-19 | 2021-03-23 | 3,370 | $2.82 | $9.5K | 430,239 | SEC↗ |
| Hutson Nancy J | Director | P Buy | 2021-03-12 | 2021-03-15 | 5,000 | $3.11 | $15.6K | 10,000 | SEC↗ |
| LASEZKAY GEORGE M | CEO | S Sale | 2021-03-02 | 2021-03-03 | 6,000 | $3.37 | $20.2K | 433,609 | SEC↗ |
| Ciulla Thomas | Chief Medical Officer | A Award deriv | 2021-03-01 | 2021-03-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Thorp Clay | Director | S Sale | 2021-02-10 | 2022-12-19 | 32,873 | $4.43 | $145.6K | 4,951,547 | SEC↗ |
| Thorp Clay | Director | S Sale | 2021-02-10 | 2021-02-12 | 32,873 | $4.43 | $145.6K | 3,433,521 | SEC↗ |
| Ciulla Thomas | Chief Medical Officer | A Award deriv | 2021-01-18 | 2021-01-20 | 209,375 | — | $0 | 209,375 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award deriv | 2021-01-18 | 2021-01-20 | 195,640 | — | $0 | 195,640 | SEC↗ |
| LASEZKAY GEORGE M | CEO | A Award deriv | 2021-01-18 | 2021-01-20 | 284,750 | — | $0 | 284,750 | SEC↗ |
| Ciulla Thomas | Chief Medical Officer | A Award | 2021-01-18 | 2021-01-20 | 103,125 | — | $0 | 253,122 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award | 2021-01-18 | 2021-01-20 | 96,360 | — | $0 | 322,187 | SEC↗ |
| LASEZKAY GEORGE M | CEO | A Award | 2021-01-18 | 2021-01-20 | 140,250 | — | $0 | 439,609 | SEC↗ |
| WHITMORE BRADFORD T | 10% Owner | P Buy | 2021-01-06 | 2021-01-07 | 350,750 | $2.85 | $999.6K | 3,529,845 | SEC↗ |
| WHITMORE BRADFORD T | 10% Owner | P Buy | 2020-12-24 | 2020-12-28 | 51,195 | $1.95 | $99.8K | 3,179,095 | SEC↗ |
| LASEZKAY GEORGE M | CEO | S Sale | 2020-12-21 | 2020-12-23 | 3,330 | $2.07 | $6.9K | 299,359 | SEC↗ |
| WHITMORE BRADFORD T | 10% Owner | P Buy | 2020-12-02 | 2020-12-02 | 53,900 | $1.95 | $105.1K | 3,127,900 | SEC↗ |
| WHITMORE BRADFORD T | 10% Owner | P Buy | 2020-11-24 | 2020-11-24 | 62,000 | $1.65 | $102.3K | 3,074,000 | SEC↗ |
| WHITMORE BRADFORD T | 10% Owner | P Buy | 2020-11-16 | 2020-11-16 | 62,000 | $1.69 | $104.8K | 3,012,000 | SEC↗ |
| LASEZKAY GEORGE M | CEO | S Sale | 2020-09-22 | 2020-09-24 | 13,411 | $1.59 | $21.3K | 302,689 | SEC↗ |
| Humphries William D. | Director | P Buy | 2020-08-18 | 2020-08-18 | 5,586 | $1.78 | $9.9K | 5,586 | SEC↗ |
| WHITMORE BRADFORD T | 10% Owner | P Buy | 2020-08-13 | 2020-08-13 | 50,000 | $1.65 | $82.5K | 2,950,000 | SEC↗ |
| WHITMORE BRADFORD T | 10% Owner | P Buy | 2020-08-13 | 2020-08-13 | 50,000 | $1.65 | $82.5K | 2,950,000 | SEC↗ |
| WHITMORE BRADFORD T | 10% Owner | P Buy | 2020-08-12 | 2020-08-13 | 300,000 | $1.63 | $489.0K | 2,900,000 | SEC↗ |
| WHITMORE BRADFORD T | 10% Owner | P Buy | 2020-08-12 | 2020-08-13 | 300,000 | $1.63 | $489.0K | 2,900,000 | SEC↗ |
| Hutson Nancy J | Director | A Award deriv | 2020-06-18 | 2020-06-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Humphries William D. | Director | A Award deriv | 2020-06-18 | 2020-06-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Croarkin Richard | Director | A Award deriv | 2020-06-18 | 2020-06-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EDWARDS JEFFREY L | Director | A Award deriv | 2020-06-18 | 2020-06-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SHAFFER CHRISTY L | Director | A Award deriv | 2020-06-18 | 2020-06-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Thorp Clay | Director, 10% Owner | A Award deriv | 2020-06-18 | 2020-06-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | S Sale | 2020-06-01 | 2020-06-03 | 14,992 | $1.88 | $28.2K | 220,827 | SEC↗ |
| Hutson Nancy J | Director | P Buy | 2020-05-20 | 2020-05-21 | 5,000 | $1.85 | $9.3K | 5,000 | SEC↗ |
| LASEZKAY GEORGE M | CEO | S Sale | 2020-05-12 | 2020-05-13 | 32,150 | $1.99 | $64.0K | 311,100 | SEC↗ |
| Hutson Nancy J | Director | A Award deriv | 2020-04-21 | 2020-04-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| LASEZKAY GEORGE M | CEO | A Award | 2020-03-11 | 2020-03-13 | 50,000 | — | $0 | 343,250 | SEC↗ |
| LASEZKAY GEORGE M | CEO | A Award deriv | 2020-01-08 | 2020-01-10 | 198,750 | — | $0 | 198,750 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award deriv | 2020-01-08 | 2020-01-10 | 75,000 | — | $0 | 75,000 | SEC↗ |
| LASEZKAY GEORGE M | CEO | A Award | 2020-01-08 | 2020-01-10 | 66,250 | — | $0 | 288,250 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award | 2020-01-08 | 2020-01-10 | 25,000 | — | $0 | 228,856 | SEC↗ |
| Thorp Clay | Director, 10% Owner | A Award | 2019-11-22 | 2019-11-26 | 1,518,026 | $1.05 | $1.59M | 4,984,420 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | P Buy | 2019-11-12 | 2019-11-13 | 7,500 | $1.14 | $8.6K | 203,856 | SEC↗ |
| LASEZKAY GEORGE M | CEO | P Buy | 2019-11-11 | 2019-11-12 | 12,000 | $1.16 | $13.9K | 222,000 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award | 2019-09-18 | 2019-09-20 | 70,000 | — | $0 | 196,356 | SEC↗ |
| LASEZKAY GEORGE M | CEO | A Award | 2019-09-18 | 2019-09-20 | 110,000 | — | $0 | 210,000 | SEC↗ |
| LASEZKAY GEORGE M | CEO | A Award | 2019-08-07 | 2019-08-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Croarkin Richard | Director | A Award deriv | 2019-06-20 | 2019-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EDWARDS JEFFREY L | Director | A Award deriv | 2019-06-20 | 2019-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Humphries William D. | Director | A Award deriv | 2019-06-20 | 2019-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Thorp Clay | Director, 10% Owner | A Award deriv | 2019-06-20 | 2019-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SHAFFER CHRISTY L | Director | A Award deriv | 2019-06-20 | 2019-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award | 2019-05-31 | 2019-06-04 | 50,000 | — | $0 | 126,356 | SEC↗ |
| Raymond Brion S. | Chief Commercial Officer | A Award | 2019-05-31 | 2019-06-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LASEZKAY GEORGE M | Interim CEO | A Award deriv | 2019-04-07 | 2019-04-10 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | P Buy | 2019-03-15 | 2019-03-18 | 10,000 | $1.36 | $13.6K | 76,356 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award deriv | 2019-02-05 | 2019-02-07 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Raymond Brion S. | Chief Commercial Officer | A Award deriv | 2019-02-05 | 2019-02-07 | 100,000 | — | $0 | 100,000 | SEC↗ |
| White Daniel H. | President and CEO | A Award deriv | 2019-02-05 | 2019-02-07 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Thorp Clay | Director, 10% Owner | P Buy | 2018-12-06 | 2018-12-06 | 8,000 | $1.36 | $10.9K | 8,000 | SEC↗ |
| EDWARDS JEFFREY L | Director | A Award deriv | 2018-09-26 | 2018-09-28 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Cagle Gerald D. | Director | M Exercise deriv | 2018-06-25 | 2018-06-26 | 2,632 | — | $0 | 0 | SEC↗ |
| Cagle Gerald D. | Director | M Exercise deriv | 2018-06-25 | 2018-06-26 | 8,618 | — | $0 | 0 | SEC↗ |
| Cagle Gerald D. | Director | M Exercise | 2018-06-25 | 2018-06-26 | 2,632 | $9.11 | $24.0K | 80,145 | SEC↗ |
| Cagle Gerald D. | Director | M Exercise | 2018-06-25 | 2018-06-26 | 8,618 | $8.81 | $75.9K | 77,513 | SEC↗ |
| Cagle Gerald D. | Director | A Award deriv | 2018-06-20 | 2018-06-21 | 11,250 | — | $0 | 11,250 | SEC↗ |
| Croarkin Richard | Director | A Award deriv | 2018-06-20 | 2018-06-21 | 11,250 | — | $0 | 11,250 | SEC↗ |
| Humphries William D. | Director | A Award deriv | 2018-06-20 | 2018-06-21 | 11,250 | — | $0 | 11,250 | SEC↗ |
| LASEZKAY GEORGE M | Director | A Award deriv | 2018-06-20 | 2018-06-21 | 11,250 | — | $0 | 11,250 | SEC↗ |
| SHAFFER CHRISTY L | Director | A Award deriv | 2018-06-20 | 2018-06-21 | 11,250 | — | $0 | 11,250 | SEC↗ |
| Thorp Clay | Director, 10% Owner | A Award deriv | 2018-06-20 | 2018-06-21 | 11,250 | — | $0 | 11,250 | SEC↗ |
| Zaytsev Evgeny | Director | A Award deriv | 2018-06-20 | 2018-06-21 | 11,250 | — | $0 | 11,250 | SEC↗ |
| White Daniel H. | President and CEO | P Buy | 2018-06-04 | 2018-06-04 | 11,000 | $9.07 | $99.8K | 483,335 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2018-05-18 | 2018-05-21 | 61,139 | $13.16 | $804.6K | 3,466,394 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2018-05-17 | 2018-05-21 | 100,000 | $13.03 | $1.30M | 3,527,533 | SEC↗ |
| Cagle Gerald D. | Director | M Exercise deriv | 2018-05-11 | 2018-05-15 | 45,454 | — | $0 | 0 | SEC↗ |
| Cagle Gerald D. | Director | M Exercise | 2018-05-11 | 2018-05-15 | 45,454 | $0.40 | $18.2K | 68,895 | SEC↗ |
| White Daniel H. | President and CEO | G Gift | 2018-03-28 | 2018-06-04 | 2,000 | — | $0 | 472,335 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2018-03-23 | 2018-03-23 | 5,231 | $12.02 | $62.9K | 3,627,533 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | P Buy | 2018-03-23 | 2018-03-26 | 500 | $11.79 | $5.9K | 66,356 | SEC↗ |
| Cagle Gerald D. | Director | P Buy | 2018-03-22 | 2018-03-23 | 7,500 | $11.89 | $89.2K | 23,441 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2018-03-22 | 2018-03-23 | 33,630 | $12.07 | $405.9K | 3,632,764 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2018-03-21 | 2018-03-23 | 100,000 | $12.27 | $1.23M | 3,666,394 | SEC↗ |
| Raymond Brion S. | Chief Commercial Officer | A Award deriv | 2018-02-26 | 2018-02-27 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award deriv | 2017-12-08 | 2017-12-12 | 96,000 | — | $0 | 96,000 | SEC↗ |
| White Daniel H. | President and CEO | A Award deriv | 2017-12-08 | 2017-12-12 | 221,500 | — | $0 | 221,500 | SEC↗ |
| Noronha Glenn | Chief Scientific Officer | A Award deriv | 2017-12-08 | 2017-12-12 | 96,000 | — | $0 | 96,000 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-12-07 | 2017-12-07 | 5,000 | $6.13 | $30.6K | 3,766,394 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-12-06 | 2017-12-07 | 15,000 | $6.09 | $91.3K | 3,771,394 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-12-05 | 2017-12-07 | 15,000 | $6.37 | $95.5K | 3,786,394 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-11-16 | 2017-11-16 | 5,000 | $6.99 | $35.0K | 3,801,394 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-11-15 | 2017-11-16 | 15,000 | $6.99 | $104.8K | 3,806,394 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-11-14 | 2017-11-16 | 15,000 | $7.02 | $105.3K | 3,821,394 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-10-19 | 2017-10-23 | 400 | $7.81 | $3.1K | 35,309 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-10-19 | 2017-10-23 | 3,600 | $7.81 | $28.1K | 474,335 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-10-18 | 2017-10-23 | 3,600 | $7.82 | $28.2K | 477,935 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-10-18 | 2017-10-23 | 400 | $7.82 | $3.1K | 35,709 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-10-05 | 2017-10-05 | 6,000 | $8.34 | $50.0K | 3,836,394 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-10-04 | 2017-10-05 | 14,000 | $8.59 | $120.3K | 3,842,394 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-10-03 | 2017-10-05 | 15,000 | $8.64 | $129.6K | 3,856,394 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-09-15 | 2017-09-15 | 10,000 | $7.54 | $75.4K | 3,871,394 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-09-14 | 2017-09-15 | 6,000 | $7.52 | $45.1K | 3,881,394 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-09-13 | 2017-09-15 | 8,500 | $7.49 | $63.7K | 3,887,394 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-09-08 | 2017-09-11 | 5,400 | $7.63 | $41.2K | 481,535 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-09-08 | 2017-09-11 | 600 | $7.63 | $4.6K | 36,109 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-09-07 | 2017-09-11 | 9,000 | $7.53 | $67.8K | 486,935 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-09-07 | 2017-09-11 | 1,000 | $7.53 | $7.5K | 36,709 | SEC↗ |
| SHAFFER CHRISTY L | Director | P Buy | 2017-08-15 | 2017-08-16 | 1,100 | $7.00 | $7.7K | 4,400 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | P Buy | 2017-08-14 | 2017-08-14 | 1,000 | $7.07 | $7.1K | 65,309 | SEC↗ |
| Cagle Gerald D. | Director | P Buy | 2017-08-11 | 2017-08-15 | 5,000 | $7.08 | $35.4K | 15,941 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-08-09 | 2017-08-09 | 15,000 | $7.30 | $109.5K | 3,895,894 | SEC↗ |
| LASEZKAY GEORGE M | Director | A Award deriv | 2017-08-08 | 2017-08-10 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-08-08 | 2017-08-09 | 5,000 | $7.98 | $39.9K | 3,910,894 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-08-07 | 2017-08-09 | 4,500 | $8.02 | $36.1K | 3,915,894 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-07-20 | 2017-07-21 | 400 | $9.71 | $3.9K | 37,709 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-07-20 | 2017-07-21 | 3,600 | $9.71 | $35.0K | 496,367 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-07-19 | 2017-07-21 | 400 | $9.79 | $3.9K | 38,109 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-07-19 | 2017-07-21 | 3,600 | $9.79 | $35.2K | 499,967 | SEC↗ |
| SHAFFER CHRISTY L | Director | A Award deriv | 2017-06-30 | 2017-07-05 | 2,632 | — | $0 | 2,632 | SEC↗ |
| Cagle Gerald D. | Director | A Award deriv | 2017-06-30 | 2017-07-05 | 2,632 | — | $0 | 2,632 | SEC↗ |
| Humphries William D. | Director | A Award deriv | 2017-06-30 | 2017-07-05 | 2,632 | — | $0 | 2,632 | SEC↗ |
| Croarkin Richard | Director | A Award deriv | 2017-06-30 | 2017-07-05 | 2,632 | — | $0 | 2,632 | SEC↗ |
| Yoon Derek | Director | A Award deriv | 2017-06-30 | 2017-07-05 | 2,632 | — | $0 | 2,632 | SEC↗ |
| Zaytsev Evgeny | Director | A Award deriv | 2017-06-30 | 2017-07-05 | 2,632 | — | $0 | 2,632 | SEC↗ |
| Thorp Clay | Director, 10% Owner | A Award deriv | 2017-06-30 | 2017-07-05 | 2,632 | — | $0 | 2,632 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award | 2017-06-30 | 2017-07-05 | 1,550 | $7.74 | $12.0K | 64,309 | SEC↗ |
| White Daniel H. | President and CEO | A Award | 2017-06-30 | 2017-07-05 | 3,100 | $7.74 | $24.0K | 503,567 | SEC↗ |
| SHAFFER CHRISTY L | Director | A Award deriv | 2017-06-22 | 2017-06-23 | 8,618 | — | $0 | 8,618 | SEC↗ |
| Cagle Gerald D. | Director | A Award deriv | 2017-06-22 | 2017-06-23 | 8,618 | — | $0 | 8,618 | SEC↗ |
| Croarkin Richard | Director | A Award deriv | 2017-06-22 | 2017-06-23 | 8,618 | — | $0 | 8,618 | SEC↗ |
| Humphries William D. | Director | A Award deriv | 2017-06-22 | 2017-06-23 | 8,618 | — | $0 | 8,618 | SEC↗ |
| Thorp Clay | Director, 10% Owner | A Award deriv | 2017-06-22 | 2017-06-23 | 8,618 | — | $0 | 8,618 | SEC↗ |
| Yoon Derek | Director | A Award deriv | 2017-06-22 | 2017-06-23 | 8,618 | — | $0 | 8,618 | SEC↗ |
| Zaytsev Evgeny | Director | A Award deriv | 2017-06-22 | 2017-06-23 | 8,618 | — | $0 | 8,618 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-06-14 | 2017-06-14 | 3,600 | $7.99 | $28.8K | 500,467 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-06-14 | 2017-06-14 | 400 | $7.99 | $3.2K | 38,509 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-06-13 | 2017-06-14 | 400 | $7.78 | $3.1K | 38,909 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-06-13 | 2017-06-14 | 3,600 | $7.78 | $28.0K | 504,067 | SEC↗ |
| SHAFFER CHRISTY L | Director | P Buy | 2017-05-22 | 2017-05-23 | 1,100 | $8.00 | $8.8K | 3,300 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-05-19 | 2017-05-19 | 15,000 | $8.31 | $124.7K | 3,920,394 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-05-18 | 2017-05-19 | 400 | $8.44 | $3.4K | 39,309 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-05-18 | 2017-05-19 | 3,600 | $8.44 | $30.4K | 507,667 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-05-18 | 2017-05-19 | 9,000 | $8.44 | $76.0K | 3,935,394 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-05-17 | 2017-05-17 | 19,000 | $8.39 | $159.4K | 3,944,394 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-05-17 | 2017-05-19 | 400 | $8.38 | $3.4K | 39,709 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-05-17 | 2017-05-19 | 3,600 | $8.38 | $30.2K | 511,267 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-05-16 | 2017-05-17 | 9,544 | $8.61 | $82.2K | 3,963,394 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-05-15 | 2017-05-17 | 15,941 | $8.94 | $142.5K | 3,972,938 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-04-19 | 2017-04-19 | 2,030 | $7.37 | $15.0K | 3,988,879 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-04-18 | 2017-04-19 | 44,455 | $7.48 | $332.5K | 3,990,909 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-04-17 | 2017-04-19 | 22,000 | $7.43 | $163.5K | 4,035,364 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-04-04 | 2017-04-05 | 400 | $7.54 | $3.0K | 40,109 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-04-04 | 2017-04-05 | 3,600 | $7.54 | $27.1K | 523,617 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-04-03 | 2017-04-05 | 400 | $7.56 | $3.0K | 40,509 | SEC↗ |
| White Daniel H. | President and CEO | S Sale | 2017-04-03 | 2017-04-05 | 3,600 | $7.56 | $27.2K | 527,217 | SEC↗ |
| Cagle Gerald D. | Director | P Buy | 2017-03-27 | 2017-05-01 | 14,064 | $7.10 | $99.9K | 14,064 | SEC↗ |
| SHAFFER CHRISTY L | Director | P Buy | 2017-03-20 | 2017-03-22 | 2,200 | $6.90 | $15.2K | 2,200 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-03-16 | 2017-03-17 | 21,485 | $6.77 | $145.5K | 4,057,364 | SEC↗ |
| Cagle Gerald D. | Director | P Buy | 2017-03-16 | 2017-03-20 | 5,000 | $6.84 | $34.2K | 10,941 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-03-15 | 2017-03-17 | 47,000 | $6.47 | $304.1K | 4,078,849 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-02-22 | 2017-02-22 | 2,000 | $7.49 | $15.0K | 4,125,849 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-02-21 | 2017-02-22 | 25,000 | $7.55 | $188.8K | 4,127,849 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-02-17 | 2017-02-17 | 10,000 | $7.54 | $75.4K | 4,152,849 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-02-16 | 2017-02-17 | 14,000 | $7.58 | $106.1K | 4,162,849 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-02-15 | 2017-02-17 | 17,485 | $7.64 | $133.6K | 4,176,849 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-01-20 | 2017-01-20 | 8,000 | $7.77 | $62.2K | 4,194,334 | SEC↗ |
| Hatteras Venture Advisors III, | 10% Owner | S Sale | 2017-01-19 | 2017-01-19 | 6,478 | $8.22 | $53.2K | 1,757,719 | SEC↗ |
| Reed Douglas MD | 10% Owner | S Sale | 2017-01-19 | 2017-01-19 | 7,592 | $8.22 | $62.4K | 2,060,514 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-01-19 | 2017-01-20 | 15,485 | $8.23 | $127.4K | 4,202,334 | SEC↗ |
| Hatteras Venture Advisors III, | 10% Owner | S Sale | 2017-01-18 | 2017-01-19 | 10,457 | $8.64 | $90.3K | 1,764,197 | SEC↗ |
| Reed Douglas MD | 10% Owner | S Sale | 2017-01-18 | 2017-01-19 | 12,258 | $8.64 | $105.9K | 2,068,106 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-01-18 | 2017-01-20 | 25,000 | $8.64 | $216.0K | 4,217,819 | SEC↗ |
| Hatteras Venture Advisors III, | 10% Owner | S Sale | 2017-01-17 | 2017-01-19 | 8,366 | $8.92 | $74.6K | 1,774,654 | SEC↗ |
| Reed Douglas MD | 10% Owner | S Sale | 2017-01-17 | 2017-01-19 | 9,806 | $8.92 | $87.5K | 2,080,364 | SEC↗ |
| Thorp Clay | Director, 10% Owner | S Sale | 2017-01-17 | 2017-01-20 | 20,000 | $8.92 | $178.4K | 4,242,819 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award deriv | 2016-12-15 | 2016-12-19 | 96,000 | — | $0 | 96,000 | SEC↗ |
| White Daniel H. | President and CEO | A Award deriv | 2016-12-15 | 2016-12-19 | 238,000 | — | $0 | 238,000 | SEC↗ |
| Noronha Glenn | Chief Scientific Officer | A Award deriv | 2016-12-15 | 2016-12-19 | 73,000 | — | $0 | 73,000 | SEC↗ |
| Noronha Glenn | Executive Vice President, R& | A Award deriv | 2016-07-21 | 2016-07-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| White Daniel H. | President and CEO | A Award deriv | 2016-07-21 | 2016-07-25 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Deignan Charles A. | Chief Financial Officer | A Award deriv | 2016-07-21 | 2016-07-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Thorp Clay | Director, 10% Owner | C Conversion deriv | 2016-06-07 | 2016-06-07 | 1,654,531 | — | $0 | 0 | SEC↗ |
| Thorp Clay | Director, 10% Owner | X Exercise deriv | 2016-06-07 | 2016-06-07 | 1,805 | — | $0 | 0 | SEC↗ |
| Thorp Clay | Director, 10% Owner | X Exercise deriv | 2016-06-07 | 2016-06-07 | 19,900 | — | $0 | 0 | SEC↗ |
| Thorp Clay | Director, 10% Owner | X Exercise deriv | 2016-06-07 | 2016-06-07 | 21,705 | — | $0 | 0 | SEC↗ |
| Thorp Clay | Director, 10% Owner | C Conversion deriv | 2016-06-07 | 2016-06-07 | 4,071,815 | — | $0 | 0 | SEC↗ |
| Thorp Clay | Director, 10% Owner | C Conversion deriv | 2016-06-07 | 2016-06-07 | 865,881 | — | $0 | 0 | SEC↗ |
| Thorp Clay | Director, 10% Owner | C Conversion deriv | 2016-06-07 | 2016-06-07 | 675,795 | — | $0 | 0 | SEC↗ |
| INGRAM ROBERT ALEXANDER | 10% Owner | C Conversion deriv | 2016-06-07 | 2016-06-07 | 337,897 | — | $0 | 0 | SEC↗ |
| INGRAM ROBERT ALEXANDER | 10% Owner | C Conversion deriv | 2016-06-07 | 2016-06-07 | 2,035,908 | — | $0 | 0 | SEC↗ |
| INGRAM ROBERT ALEXANDER | 10% Owner | X Exercise deriv | 2016-06-07 | 2016-06-07 | 21,705 | — | $0 | 0 | SEC↗ |
| INGRAM ROBERT ALEXANDER | 10% Owner | C Conversion deriv | 2016-06-07 | 2016-06-07 | 432,941 | — | $0 | 0 | SEC↗ |
| INGRAM ROBERT ALEXANDER | 10% Owner | C Conversion deriv | 2016-06-07 | 2016-06-07 | 689,388 | — | $0 | 0 | SEC↗ |
| INGRAM ROBERT ALEXANDER | 10% Owner | X Exercise deriv | 2016-06-07 | 2016-06-07 | 1,805 | — | $0 | 0 | SEC↗ |
| INGRAM ROBERT ALEXANDER | 10% Owner | X Exercise deriv | 2016-06-07 | 2016-06-07 | 19,900 | — | $0 | 0 | SEC↗ |
| INGRAM ROBERT ALEXANDER | 10% Owner | C Conversion deriv | 2016-06-07 | 2016-06-07 | 337,898 | — | $0 | 0 | SEC↗ |
| INGRAM ROBERT ALEXANDER | 10% Owner | C Conversion deriv | 2016-06-07 | 2016-06-07 | 432,940 | — | $0 | 0 | SEC↗ |
| INGRAM ROBERT ALEXANDER | 10% Owner | C Conversion deriv | 2016-06-07 | 2016-06-07 | 689,388 | — | $0 | 0 | SEC↗ |
| INGRAM ROBERT ALEXANDER | 10% Owner | C Conversion deriv | 2016-06-07 | 2016-06-07 | 2,035,907 | — | $0 | 0 | SEC↗ |
| RusnanoMedInvest LLC | 10% Owner | C Conversion deriv | 2016-06-07 | 2016-06-07 | 2,594,677 | — | $0 | 0 | SEC↗ |